Transcription of 審議結果報告書 平成 28 - pmda.go.jp
{{id}} {{{paragraph}}}
Example: tourism industry
審議結果報告書 平成 28 - pmda.go.jp
28 11 16 .. 25 mg .. 28 3 31 .. 28 11 11 .. 10 .. 28 10 18 .. 25 mg .. 28 3 31 . 1 28 mg . 25 mg . 1 .. NH2. O CH3. N O H. N N. P O CH3 CO2H. N N O O CH. H HO2C. 3. H. CH3. 2. (C21H29N6O5P)2 C4H4O4.. N-[(S)-{[(1R)-2-(6- -9H- -9- )-1- ] } ]-L- . 1- .. 1-Methylethyl N-[(S)-{[(1R)-2-(6-amino-9H-purin-9-yl)- 1-methylethoxy]methyl}phenoxyphosphinoyl ]-L- alaninate hemifumarate 28 4 12 0412 2 .. B .. B B B .. 1 25mg 1 1 .. 2.. 1 . 28 9 6 .. 25 mg .. 28 3 31 . 1 28 mg . 25 mg . B B . B . 1 25mg . 28mg 1 1 .. 1. 1.. 4. 2.. 5. 3.. 6. 4.. 8. 5.. 9. 6. 10. 7.. 16. 8.. 33. 9. 1 .. 33.. ADV Adefovir pivoxil . ALT Alanine aminotransferase . ATV Atazanavir . AUC Area under the plasma concentration versus . time curve AUCinf AUC extrapolated to infinite time 0 AUC.
審議結果報告書 平成28年 11月 16日 医薬・生活衛生局医薬品審査管理課 [販売名] ベムリディ錠25 mg [一般名] テノホビル アラフェナミドフマル酸塩
Loading..
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: